Yale's EGFR/HER2 Vaccine - Prof. Mark Mamula
Updated: Mar 20, 2021
On Oct 3, 2020 CCRA hosted a scientific seminar by Professor Mark Mamula where he described his team's work on EGFR-peptide canine cancer vaccine. A summary of the work is described in a previous blog.
Here, we provide
the recording of the seminar,
the slides from the seminar, and
the story of Ranger - a golden retriever whose pulmonary metastasis disappeared after receiving vaccine injections.
According to Prof. Mamula, a subset of dogs (5-6 dogs) with osteosarcomain his study have experienced resolving of pulmonary metastasis. His data will soon be published in a peer-reviewed journal.
Lecture and Q&A - Professor Mark Mamula
Ranger is a golden retriever who was diagnosed with osteosarcoma in spring of 2019. After amputation surgery and chemotherapy treatment, he developed pulmonary metastasis by fall of 2019. His tumor disappeared after the vaccine treatment, as described by Ranger's dad, Rick Kneisel.